News from CROI 2024

PDF: Long-Acting Cabotegravir Plus Rilpivirine in Adolescents with HIV: Week 24 IMPAACT 2017 Study

Protocol: IMPAACT 2017/ MOCHA

Authors: Gaur A, Capparelli E, Baltrusaitis K, Marzinke M, Harrington C, McCoig C, Crauwels H, Townley E, Moye J, Buisson S, Violari A, Ounchanum P, Krotje C, Bolton Moore C, IMPAACT 2017 Team

PDF: Hypertension in a Randomized Trial of DTG vs EFV-based ART in Pregnant and Postpartum Women

Protocol: IMPAACT 2010/VESTED

Authors: Hoffman R, Brummel S, Pinilla M, Malonga G, Chinula L, Hanley S, Stranix-Chibanda L, Machado ES, Naik S, McCarthy K, Krotje C, Jean-Philippe P, Sax P, Currier J, Lockman S

Protocol: IMPAACT P1115

Authors: Persaud D, Coletti A, Nelson BS, Jao J, Capparelli E, Costello D, Tierney C, Kekitiinwa AR, Nematadzira T, Njau BN, Moye J, Jean-Philippe P, Bryson Y, Chadwick EG, for the IMPAACT P1115 Study Team

1077BF: Breast Milk Reservoir, Tenofovir levels and HIV Transmission Among Breastfeeding Mothers
Owor M, DeMarrais P, Baltrusaitis K, Frenkel LM, Best B, Stranix Chibanda L, Mallewa M, Kamthunzi P, Moodley D, Violari A, Chipato T, Kakayi B, Bhosale R, Fowler MG

Metabolomic Perturbations of Tryptophan and Arginine Metabolites in the Breast Milk of Women With HIV
Tobin NH, Li F, Ferbas KG, Sleasman JW, Kuhn L, Aldrovandi GM, for the ZEBS study team

Pharmacokinetics of Isoniazid Metabolites During Pregnancy and Postpartum
Klein B, Wei Z, Nerguizian D, Gupta A, Weinberg A, Montepiedra G, Morrow M, MaWhinney S, Musoke P, Auripibul L, Masheto G, Bushman L, Anderson PL, Brooks KM

A Single Once Daily ABC/DTG/3TC Tablet Predicts Safe and Effective Exposures in Children 3 to <6kg
Chandasana H, Brooks K, Buchanan AM, Tan L, Mujuru H, Colbers A, Hopking J, Cuiffa M, McKenna M, Wiznia A, Brummel S, Bekker A, Cressey T, Rabie H

Population Pharmacokinetics ABC/DTG/3TC FDC to Support Dosing in Peds with HIV-1 (IMPAACT 2019)
Chandasana H, van Dijkman S, Mehta R, Bush M, Rabie H, Flynn P, Cressey TR, Acosta E, Brooks KM, for the IMPAACT 2019 Protocol Team

Dolutegravir and Growth in Pediatric Populations With HIV-1: IMPAACT P1093 and IMPAACT 2019
McKenna M, Lulic Z, Buchanan AM, Brothers C, Tan L, Wang M, Brummel S, Ziemba L, Ruel T, Flynn PM, Rabie H, Wiznia A

Breast Milk Transfer and Infant Exposures to DTG, TAF, and TFV: Results from IMPAACT 2010/VESTED
Nguyen T, Chae JW, Ziemba L, Coletti A, Knowles K, Johnston B, Jean-Philippe P, Mhembere T, Chawana T, Wabwire D, Korutaro V, Lockman S, Chinula L, Momper J, on behalf of the IMPAACT 2010/VESTED Protocol Team

Cabotegravir PopPK Analysis of Adults & Adolescents Living with HIV or at Risk for HIV Receiving PrEP
Lin YW, Cheung SYA, Deprez I, Ford S, Collins J, McCoig C, Harrington C, Gaur A, Bolton C, Stranix-Chibanda L, Hosek S, Marzinke M, Best B, Capparelli E, and IMPAACT 2017 team

IMPAACT 2017 Adolescent/Parent Experiences with LA Cabotegravir Plus Rilpivirine for HIV Treatment
Lowenthal ED, Chapman JC, Zapata Vaca M, Ward S, Milligan R, Camacho-Gonzalez A, Masheto G, McCoig C, Ace A, Van Solingen R, Yin D, Buisson S, Bolton C, Gaur A, IMPAACT 2017 Team

Proviral Landscape in Neonates with In Utero HIV-1 on Very Early ART in IMPAACT P1115
Bekka SK, Khetan P, Liu Y, Dhummakupt A, Nelson BS, Tierney C, Chadwick E, Jao J, Bryson Y, Coletti A, Nicodimus N, Stranix-Chibanda L, Lee GQ, Ray S, Persaud D

Lamivudine (3TC) Dosing for Preterm Neonates Exposed to HIV
Bekker A, Capparelli EV, Mirochnick M, Clarke DF, Cotton MF, Shapiro R, McCarthy K, Moye J, Violari A, Chokephaibulkit K, Abrams E, Penazzato M, Ruel T, Cressey TR

Maternal and Pregnancy Outcomes in Women Initiating and Declining PrEP in Pregnancy: IMPAACT 2009
Chi BH, Kacanek D, Brown E, Amico KR, Huang S, Nematadzira T, Horne E, Nakabiito C, Mambiya SK, Korutaro V, Johnson B, Rooney JF, Spiegel H, Stranix-Chibanda L, on behalf of the IMPAACT 2009 team